Morgan Meeks, PA
Physician Assistant · Charleston, WVNPI 1619354131
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,221 of the $4,228 with a category attached, or 76.2%. Pulmonx Corporation accounts for 89.0% of it on its own, with 6 other manufacturers making up the rest. Among physician assistant clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 19 payments — averaging $222.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pulmonx Corporation$4K
- United Therapeutics Corporation$151
- Regeneron Healthcare Solutions, Inc.$111
- Boehringer Ingelheim$87
- AstraZeneca$87
- Apria Healthcare LLC$15
- plus $14 from 1 others
What the payments were for
- Travel & lodging$3,22176%
- Food & beverage$1,00724%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pulmonx Corporation | 9 | $3,763 |
| United Therapeutics Corporation | 2 | $151 |
| Regeneron Healthcare Solutions, Inc. | 4 | $111 |
| Boehringer Ingelheim | 1 | $87 |
| AstraZeneca | 1 | $87 |
| Apria Healthcare LLC | 1 | $15 |
| Baxter Healthcare | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEPHYR ENDOBRONCHIAL VALVE$3,591
- ZEPHYR DELIVERY CATHETER$1,547
- CHARTIS CATHETER$1,547
- PULMONX CHARTIS TABLET CONSOLE$1,547
- TYVASO$126
How this compares
$4,228 in reported general payments places this provider in the 90th percentile of 833 physician assistant providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 100 | $156,941 |
| XolairOmalizumab | 26 | $90,022 |
| TezspireTezepelumab-Ekko | 12 | $54,430 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 56 | $51,976 |
| NucalaMepolizumab | 11 | $41,385 |
| SymbicortBudesonide/Formoterol Fumarate | 108 | $39,874 |
| Ambrisentan | 12 | $34,200 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $26,260 |
| Breo ElliptaFluticasone/Vilanterol | 31 | $24,502 |
| Spiriva HandihalerTiotropium Bromide | 22 | $21,531 |
| Spiriva RespimatTiotropium Bromide | 15 | $17,688 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 23 | $15,345 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 39 | $12,804 |
| Incruse ElliptaUmeclidinium Bromide | 26 | $11,256 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 382 | $11,186 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaTezspire, Symbicort, Breztri Aerosphere | $87 | $120,565143 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $87 | $33,03438 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 833 physician assistant providers in West Virginia.
Other physician assistant in Charleston
- Frances PauleyCharleston$14K
- Danielle MolinaCharleston$12K
- Jason TrustyCharleston$11K
- Kelley DotsonCharleston$8K
- Justin ClayCharleston$7K
- Randi DillonCharleston$7K
- Ashley MuellerCharleston$5K
- Yevgeniya GurevichCharleston$5K
- Cristina EddyCharleston$4K
- Benjamin ChapmanCharleston$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.